Contineum Therapeutics (CTNM) Change in Account Payables (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly Change in Account Payables came in at $490000.0 in Q1 2026, down 73.28% year-on-year from $1.8 million in Q1 2025, and up 202.47% quarter-over-quarter from $162000.0 in Q4 2025.
Contineum Therapeutics (CTNM) Change in Account Payables (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Change in Account Payables history runs 4 years deep, the most recent figure standing at $490000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 73.28% year-over-year to $490000.0 in Q1 2026; TTM through Mar 2026 was -$2.2 million, a 172.68% decrease from a year earlier, with the FY2025 full-year figure at -$869000.0, down 176.16% from the prior year.
- Change in Account Payables grew to $490000.0 in Q1 2026 per CTNM's latest filing, from $162000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.8 million in Q1 2025 and bottomed at -$1.6 million in Q2 2025.
- The 4-year median for Change in Account Payables is $170000.0 (2024), against an average of $58615.4.
- Biggest YoY gain for Change in Account Payables was 2720.0% in 2025; the steepest drop was 1067.06% in 2025.
- Year by year, Change in Account Payables stood at -$625000.0 in 2023, then jumped by 160.48% to $378000.0 in 2024, then plunged by 57.14% to $162000.0 in 2025, then jumped by 202.47% to $490000.0 in 2026.
- Per Business Quant, the three latest CTNM Change in Account Payables figures stand at $490000.0 (Q1 2026), $162000.0 (Q4 2025), and -$1.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | 490,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 490,000.00 |
| Mar 31, 2026 | 490,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | -1.22 Mn |
| Sep 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 378,000.00 |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 663,000.00 |
| Sep 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | -625,000.00 |
| Dec 31, 2023 | -625,000.00 |